Patent · US Active

Nucleoside derivatives

US8227431B2 · kind B2 · utility

0Cited by
2References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 2009
Grant dateJul 24, 2012
Priority date
Expiry dateMar 12, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present patent application relates to the novel nucleoside derivatives and novel intermediates, which are useful to antiviral, anti tumor and immunomodulatory activity, method of treating diseases, conditions and/or disorders modulated by viral infections with them, and processes for preparing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.